C4 Therapeutics, Inc. | ||||
NMS : CCCC || Location: United States | ||||
$8.17+0.12 (+1.49%) |
1.87 M | 7.86 - 8.21 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 5.287 M |
Feb. 29, 2024 | 2.967 M |
Feb. 15, 2024 | 3.177 M |
Jan. 31, 2024 | 3.354 M |
Jan. 12, 2024 | 5.550 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.70 | -0.70 | -0.55% |
09/30/2023 | -0.67 | -0.52 | 22.76% |
06/30/2023 | -0.70 | -0.73 | -4.06% |
03/31/2023 | -0.76 | -0.71 | 6.65% |
12/31/2022 | -0.76 | -0.77 | -1.50% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 68.601M | Shares Float | 52.510M |
Short Float | 5.287M | Market Cap | 552.24M |
Institution ownership | 68.09% | Insider ownership | 14.218% |
Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
Trailing EPS | -2.67 | Forward EPS | -1.92 |